COVID-19
Diagnostics & testing

Effective diagnostics are the eyes and ears of a global pandemic response

Tests are critical to help limit the spread of disease.
There is no time to waste in the fight against COVID-19.

The ACT-Accelerator

FIND is co-leading the Diagnostics Pillar of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking collaboration to reduce death and severe disease through the accelerated development, equitable allocation, and scaled up delivery of COVID-19 tests, treatments, and vaccines, thereby protecting health systems and restoring societies and economies.

Learn more about the act-accelerator

CALL FOR PROPOSALS: Accelerating the availability of affordable SARS-CoV-2 self-tests

FIND has opened a call for proposals to accelerate the availability of low-cost self-testing solutions for SARS-CoV-2 in low- and middle-income countries.

More information

Advocacy

COVID-19 has exposed how sustained underinvestment in testing has a negative impact on health, societies and economies. Managing the pandemic and building back better must put testing at the centre.

READ MORE

Investment

US$9 billion is needed to ensure equitable access to new and existing tests, including the procurement and distribution of at least 900 million molecular and antigen rapid tests.

READ MORE

Progress

Testing is the first line of defence against COVID-19. The ACT-Accelerator Diagnostics Pillar has established an ambitious agenda, aiming to achieve 10 key milestones across four workstreams by the end of 2020.

READ MORE

COVID-19 test directory & pipeline

We are tracking the current status of SARS-CoV-2 tests commercialized and in development.

For immunoassays and molecular tests for COVID-19, we have compiled a fully searchable directory that includes performance data (sensitivity and specificity).

More information

FIND evaluations of SARS-CoV-2 assays

We are conducting independent evaluations of molecular tests and immunoassays, in collaboration with WHO and multiple partners worldwide, to assist in-country decision making.

evaluations & results

Antigen rapid test implementation

FIND resources to support implementation of antigen rapid tests in your country.

READ MORE

Online courses

Join our courses to get the latest recommendations on COVID-19 testing and up-to-date information on the performance of tests and how best to deploy them.

READ MORE

Current testing situation worldwide

Our interactive map builds a picture of how many people in the world are being tested by tracking the number of SARS-CoV-2 tests reported to have been performed in each country, and comparing it with the number that showed a positive result.

INTERACTIVE SARS-CoV-2 TEST-TRACKER

Impact of novel variants of SARS-CoV-2 on diagnostic testing

Three SARS-CoV-2 variants of potential concern have recently been identified, characterized by a number of novel genetic mutations.

rEAD MORE

COVID-19 diagnostics resources

SARS-CoV-2 variants
Read more
Developing a collaborative research agenda for SARS-CoV-2 antigen rapid diagnostic tests
Read more
Framework for the governance of personal data for the Access to COVID-19 Tools Accelerator
Read more
SARS-CoV-2 antigen-detecting rapid diagnostic tests: an implementation guide
Read more
Antigen RDTs: training package
Read more
Antigen RDTs: country implementation support
Read more
ACT-Accelerator Diagnostics Pillar: No one is safe until everyone is safe
Read more
FAQs from test manufacturers
Read more
Summary of WHO COVID AG RDT Guidance
Read more
In-house test development for molecular detection of SARS-CoV-2 (En, Fr, Por)
Read more
Rapid Diagnostic Tests for Covid-19
Read more
COVID-19 in-vitro diagnostic medical devices
Read more
Access to COVID-19 Tools (ACT) Accelerator
Read more
Diagnostics for Covid-19 (Eng & Fr)
Read more
SARS-CoV-2 diagnostic use cases
Read more

Diagnostics implementation simulator

Our simulator, developed in partnership with the EPFL Blue Brain Project and Ateneo de Manila University, uses modelling data to simulate scenarios and estimate the potential impact of deploying different testing strategies for COVID-19.

DX Implementation simulator

Media & Press

COVAX reaches over 100 economies, 42 days after first international delivery
Read more
Global Fund thanks the United States for US$3.5 billion emergency investment to fight COVID-19
Read more
$5 COVID test, DIY-style, may be on the way
Read more
Can mass self-testing for Covid-19 keep schools safe?
Read more
Why the rich world cannot afford to leave the poor behind on vaccines
Read more
COVID-19 test makers are adapting for variants
Read more
Rapid coronavirus tests: a guide for the perplexed
Read more
SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
Read more
Millions of low-cost diagnostic tests to be made available to poorest nations
Read more
Aruba first government to join the CommonTrust Network
Read more
Behind the Covid-19 vaccine is a hidden arsenal of diagnostic tests
Read more
Time to tap Covid-19 innovations & systems to reimagine TB care
Read more
Covid-19 tests that give results in minutes to be rolled out across world
Read more
Decentralized HCV testing is key to finding the missing millions
Read more
Rapid, affordable, high quality COVID tests still scant
Read more
The breakthrough that could halt the pandemic, even before a vaccine
Read more
Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic
Read more
Rapid COVID-19 testing breaks free from the lab
Read more
Saving lives from COVID-19 is everyone’s responsibility
Read more
Where is the money for COVID-19 diagnostics?
Read more
‘The biggest monster’ is spreading. And it’s not the coronavirus.
Read more
Jeremy Hunt's clash with Whitty puts testing regime under the spotlight
Read more
Opinion: To enable UHC, close COVID-19 testing and gender gaps
Read more
How to cap the virus in the current situation: cast the testing net wider and act fast on the data
Read more
Three questions (Catharina Boehme)
Read more
WHO seeks $6B diagnostics support for unrelenting COVID-19 pandemic
Read more
Dr Tom Frieden: 'Blaming CDC for US Covid failures is like blaming someone encased in concrete for failing to swim'
Read more
Care in the time of COVID-19
Read more
'Global Goal: Unite for Our Future,’ Global Citizen and the European Commission mobilize $1.5 billion in cash grants, and $5.4 billion in loans and guarantees—for a total of $6.9 billion pledged—to combat the disproportionate impact of Covid-19 on vulnerable and disadvantaged communities
Read more
Developing countries face diagnostic challenges as the COVID-19 pandemic surges
Read more
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Read more
Women leaders unite to push for testing to exit COVID-19
Read more
UK R&D funding goes global
Read more
How Reliable Are COVID-19 Tests?
Read more
Who are the key players in making COVID-19 tests, treatments, and vaccines available to everyone?
Read more
Testing funds shortfall imperils Covid-19 fight, health groups warn
Read more
India needs to ensure that testing is at the heart of its response to Covid-19
Read more
Beset by COVID-19 pandemic, Europe searches for right test mix for diagnosis, surveillance
Read more
Diagnostic testing for severe acute respiratory syndrome–related Coronavirus-2: A narrative review
Read more
Is there still a case for testing contacts?
Read more
'Global goal: unite for our future': we're calling on the world to make sure everyone can beat COVID-19
Read more
La grande foire aux tests sérologiques
Read more
Global TB community must unite – 1.4 million lives are at stake
Read more
Dockyard : All about COVID-19 tests
Read more
How COVID-19 testing works
Read more
What African nations are teaching the West about fighting the coronavirus
Read more
Why the accuracy of SARS-CoV-2 antibody tests vary so much
Read more
First batch of Covid-19 test kits funded by Pepsico arrive at sites across India
Read more
PepsiCo India-funded COVID-19 testing kits start reaching laboratories
Read more
Demand for coronavirus tests raises concerns over HIV and malaria
Read more
Testing times – Letters to the Editor
Read more
Senegal working on $1 testing kit for Covid-19, say reports as number of cases in Africa cross 22,000
Read more
We must never forget TB is still out there
Read more
Q&A on COVID-19 antibody tests
Read more
Mologic launches manufacturing facility to boost access to COVID-19 rapid diagnostic tests
Read more
Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers
Read more
Diagnosing malaria and other febrile illnesses during the COVID-19 pandemic
Read more
UK ‘key’ funder of Covid-19 tests in developing nations
Read more
Ramping up diagnostics in resource-poor countries
Read more
Testing the tests: Which COVID-19 tests are most accurate?
Read more
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Read more
In scramble for coronavirus supplies, rich countries push poor aside
Read more
South Korea’s factories stretched to limit churning out virus test
Read more
This is no time for ‘America First.’ China’s coronavirus tests are good enough for the U.S.
Read more
PepsiCo India commits over 5 million meals and 25,000 COVID-19 testing kits
Read more
GlobalData: Rapid POC tests to accelerate testing capacity for diagnosing COVID-19
Read more
How do coronavirus tests work?
Read more
What coronavirus tests does the world need to track the pandemic? | Free to read
Read more
'Absolutely wrong': how UK's coronavirus test strategy unravelled
Read more
New testing kits could turn tide against coronavirus-if they work
Read more
Just 2,000 key NHS staff have been tested, UK government admits
Read more
Esto es lo que sabemos de las pruebas rápidas para detectar COVID-19
Read more
A look at COVID-19 testing and why country-wide is impossible right now
Read more
New Tests Could Turn Tide Against Coronavirus—If They Work
Read more
25,000 tests a day in UK ‘not going to be adequate’ – FIND’s Dr Rangarajan Sampath
Read more
Why the U.S. coronavirus testing failures were inevitable
Read more
Catharina Boehme: «Il y a une crise évidente dans la disponibilité des tests du coronavirus»
Read more
AIDS, TB and malaria: Coronavirus threatens the endgame
Read more
Many will say globalisation got us into this mess. In reality, it is what will get us out of it
Read more
UK Government invests $28M in FIND to support SARS-CoV-2 test development
Read more
Trump’s faulty testing claims
Read more
U.K. trials coronavirus-immunity tests for home use
Read more
Q&A: FIND's Cassandra Kelly-Cirino discusses COVID-19 diagnostics pipelines
Read more
Des tests sérologiques déployés sous peu pour voir l'étendue réelle du Covid-19 en Suisse
Read more
Fast, portable tests come online to curb coronavirus pandemic
Read more
Biden, Trump wrong about WHO coronavirus tests
Read more
COVID-19 coronavirus and tuberculosis: We need a damage control plan
Read more
Let’s worry about diagnostic capacity, not just during outbreaks
Read more
On stigma and outbreak response
Read more